MedTrace Logo

Sustainable Financial Incentives To Improve Prescription Practices For Malaria

NCT01809873 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14862

Last updated 2015-03-10

No results posted yet for this study

Summary

This project aims to test an innovative, sustainable financial incentive designed to reduce the number of non-malarial fevers that are treated inappropriately with antimalarial drugs.

Conditions

Interventions

BEHAVIORAL

Performance based incentives

Facilities enrolled in the intervention arm will receive a financial incentive that is based on their diagnosis and prescription practices for malaria over that quarter. The intervention will last 12 months.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-11-30
Completion
2014-03-31

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01809873 on ClinicalTrials.gov